A Survey of Antimicrobial Resistance Determinants in Category A Select Agents, Exempt Strains, and Near-Neighbor Species

Int J Mol Sci. 2020 Feb 29;21(5):1669. doi: 10.3390/ijms21051669.

Abstract

A dramatic increase in global antimicrobial resistance (AMR) has been well documented. Of particular concern is the dearth of information regarding the spectrum and prevalence of AMR within Category A Select Agents. Here, we performed a survey of horizontally and vertically transferred AMR determinants among Category A agents and their near neighbors. Microarrays provided broad spectrum screening of 127 Francisella spp., Yersinia spp., and Bacillus spp. strains for the presence/absence of 500+ AMR genes (or families of genes). Detecting a broad variety of AMR genes in each genus, microarray analysis also picked up the presence of an engineered plasmid in a Y. pestis strain. High resolution melt analysis (HRMA) was also used to assess the presence of quinolone resistance-associated mutations in 100 of these strains. Though HRMA was able to detect resistance-causing point mutations in B. anthracis strains, it was not capable of discriminating these point mutations from other nucleotide substitutions (e.g., arising from sequence differences in near neighbors). Though these technologies are well-established, to our knowledge, this is the largest survey of Category A agents and their near-neighbor species for genes covering multiple mechanisms of AMR.

Keywords: Antimicrobial resistance; Bacillus spp.; Francisella spp.; Yersinia spp.; high resolution melt analysis (HRMA); microarrays; quinolone resistance determining regions (QRDRs).

MeSH terms

  • Bacillus / drug effects
  • Bacillus / genetics
  • Bacillus / pathogenicity
  • Bacterial Infections / drug therapy
  • Bacterial Infections / genetics*
  • Bacterial Infections / microbiology
  • Drug Resistance, Bacterial / genetics*
  • Francisella / drug effects
  • Francisella / genetics
  • Francisella / pathogenicity
  • Gene Expression Regulation, Bacterial / drug effects
  • Humans
  • Mutation / genetics
  • Plasmids / genetics
  • Quinolones / therapeutic use*
  • Yersinia / drug effects
  • Yersinia / genetics
  • Yersinia / pathogenicity

Substances

  • Quinolones